abstract |
The invention relates to compounds of formula I their stereoisomer, enantiomer, pharmaceutically acceptable salt or amino acid conjugate, where the variables have the meanings defined in the description, and their pharmaceutical compositions that are useful as modulators of the activity of farnozoidny X-receptors (FXR). |